Berkshire Sells $69 Million Of DaVita Stock, Its Second Sale Since July
Berkshire and Warren Buffett still report 28.3 million DaVita shares after Tuesday's open-market sale at an average $180.43.
Berkshire Hathaway sold 382,563 DaVita shares at an average $180.43 on Tuesday, a $69.0 million open-market sale, according to an SEC filing made Thursday jointly with Warren Buffett. It is the second sale filing since July 31.
Two sales, $105.5 million
The earlier sale came on July 31, when Berkshire sold 182,980 shares at about $199.55, or $36.5 million. Counting Tuesday's trade, the two sale filings since July 31 total 565,543 shares and $105.5 million.
Tuesday's sale was priced well below that July level. DaVita shares closed at $193.31 on Thursday.
What Berkshire still holds
After the sale, the filing group reports 28,314,666 DaVita shares, all on an indirect line, worth about $5.47 billion at Thursday's close. Tuesday's sale equals 1.33% of the group's prior holdings.
The shares sit in two places. Government Employees Insurance Company, a Berkshire subsidiary, owns 13,341,058 of them. Another 14,973,608 are held by pension plans of Berkshire's subsidiaries: 4,441,520 in the BNSF Master Retirement Trust and 10,532,088 in the Berkshire Hathaway Inc. Consolidated Pension Plan.
Buffett is the controlling stockholder of Berkshire and says he owns the reported shares only to the extent of his financial stake in them. Berkshire, Buffett and the pension plans disclaim beneficial ownership of the pension-held shares.
The dialysis business behind the stock
DaVita provides kidney care, with dialysis for patients whose kidneys have failed as its core service. Its U.S. dialysis unit treated about 200,500 patients at the end of 2025 through 2,657 outpatient centers in 46 states and the District of Columbia, and made up about 86% of 2025 revenue, according to its annual report.
That revenue is paid mostly by government programs such as Medicare and Medicaid, with commercial insurers covering the rest. Internationally, DaVita served about 94,500 patients through 585 centers in 14 countries.
Any further Berkshire sale filings on DaVita would extend the tally that now stands at 565,543 shares since July 31.
Sources
- Form 4 — Warren Buffett (DVA) — SEC EDGAR